EUVIMEDEUVIMED entdecken
Open Access

In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children

Tzy-Jyun Yao iD, Kathleen Malee, Joel Zhang, Renee Smith, Sean Redmond, Mabel L Rice, Toni Frederick, Peter Torre, Claude A Mellins, Howard J Hoffman, Paige L Williams

AIDS Patient Care and STDs · 2023

DOI: 10.1089/apc.2022.0189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIDS Patient Care and STDs, 2023. Verfasst von Tzy-Jyun Yao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: HIV Infections, Pregnancy Complications, Infectious, Acquired Immunodeficiency Syndrome, Anti-HIV Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Studies have observed neurodevelopmental (ND) challenges among young children perinatally HIV-exposed yet uninfected (CHEU) with in utero antiretroviral (ARV) exposure, without clear linkage to specific ARVs. Atazanavir (ATV) boosted with ritonavir has been a preferred protease inhibitor recommended for pregnant women, yet associations of ATV with ND problems in CHEU have been reported. Studies among early school-age children are lacking. The pediatric HIV/AIDS cohort study (PHACS) surveillance monitoring for antiretroviral therapy (ART) toxicities (SMARTT) study evaluated 5-year-old monolingual English-speaking CHEU using the behavior assessment system for children, Wechsler preschool and primary scales of intelligence, and test of language development-primary. A score ≥1.5 standard deviations worse than population norms defined a signal within each domain. Analyses of risk for signals were stratified by timing of any ARV initiation. Associations between ARV exposure and risk of ND signals were assessed using proportional odds models, adjusting for confounders. Among 230 children exposed to ARVs at conception, 15% had single and 8% had multiple ND problems; ATV exposure was not associated with higher risk of signals [adjusted cumulative odds ratio (cOR) = 0.66, confidence interval (CI): 0.28-1.56]. However, among 461 children whose mothers initiated ARVs during pregnancy, 21% had single and 12% had multiple ND problems; ATV exposure was associated with higher risk of signals (cOR = 1.70, CI: 0.82-3.54). The specific regimen tenofovir/emtricitabine/ATV was associated with higher risk (cOR = 2.31, CI: 1.08-4.97) relative to regimens using a zidovudine/lamivudine backbone combined with non-ATV ARVs. It remains important to monitor neurodevelopment of CHEU during early childhood and investigate the impact and the role of timing of in utero exposure to specific ARVs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsPregnancy Complications, InfectiousAcquired Immunodeficiency SyndromeAnti-HIV AgentsPregnancyHumansChild, PreschoolFemaleChildCohort StudiesInfectious Disease Transmission, VerticalAnti-Retroviral Agents

Stichwörter der Autor:innen

antiretroviralconcomitant neurodevelopmental problemsprenatalpreschool

Substanzen

Anti-Retroviral AgentsAnti-HIV Agents

Autor:innen und Institutionen

  • Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • The conclusions and opinions expressed in this article are those of the authors and do not necessarily reflect those of the National Institutes of Health or US Department of Health and Human Services.
  • Psychiatry and Behavioral Science, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Department of Pediatrics, University of Illinois at Chicago Children's Hospital, Chicago, Illinois, USA.
  • Department of Communication Sciences and Disorders, University of Utah, Salt Lake City, Utah, USA.
  • Child Language Doctoral Program, Department of Speech, Language and Hearing, University of Kansas, Lawrence, Kansas, USA.

ORCID-Profile: Tzy-Jyun Yao

Förderung

  • NICHD NIH HHS

Zitieren

APA

Yao, T. J., Malee, K., Zhang, J., Smith, R., Redmond, S., Rice, M. L., Frederick, T., Torre, P., Mellins, C. A., Hoffman, H. J., & Williams, P. L. (2023). In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children. AIDS Patient Care and STDs. https://doi.org/10.1089/apc.2022.0189

Vancouver

Yao TJ, Malee K, Zhang J, Smith R, Redmond S, Rice ML, et al. In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children. AIDS Patient Care and STDs. 2023. doi:10.1089/apc.2022.0189

BibTeX
@article{Yao2023,
  author = {Yao, Tzy-Jyun and Malee, Kathleen and Zhang, Joel and Smith, Renee and Redmond, Sean and Rice, Mabel L and Frederick, Toni and Torre, Peter and Mellins, Claude A and Hoffman, Howard J and Williams, Paige L},
  title = {In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children},
  journal = {AIDS Patient Care and STDs},
  year = {2023},
  doi = {10.1089/apc.2022.0189}
}
Kostenlos starten →